- Home
- RAPT vs OCCI Comparison
RAPT vs OCCI Comparison
Compare RAPT & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- OCCI
- Stock Information
- Founded
- RAPT 2015
- OCCI N/A
- Country
- RAPT United States
- OCCI United States
- Employees
- RAPT N/A
- OCCI N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- OCCI Trusts Except Educational Religious and Charitable
- Sector
- RAPT Health Care
- OCCI Finance
- Exchange
- RAPT Nasdaq
- OCCI Nasdaq
- Market Cap
- RAPT 194.2M
- OCCI 160.5M
- IPO Year
- RAPT 2019
- OCCI N/A
- Fundamental
- Price
- RAPT $13.18
- OCCI $5.89
- Analyst Decision
- RAPT Buy
- OCCI
- Analyst Count
- RAPT 5
- OCCI 0
- Target Price
- RAPT $33.60
- OCCI N/A
- AVG Volume (30 Days)
- RAPT 117.5K
- OCCI 115.8K
- Earning Date
- RAPT 08-07-2025
- OCCI 12-11-2023
- Dividend Yield
- RAPT N/A
- OCCI 24.32%
- EPS Growth
- RAPT N/A
- OCCI N/A
- EPS
- RAPT N/A
- OCCI N/A
- Revenue
- RAPT N/A
- OCCI N/A
- Revenue This Year
- RAPT N/A
- OCCI N/A
- Revenue Next Year
- RAPT N/A
- OCCI $10.19
- P/E Ratio
- RAPT N/A
- OCCI N/A
- Revenue Growth
- RAPT N/A
- OCCI N/A
- 52 Week Low
- RAPT $5.67
- OCCI $5.47
- 52 Week High
- RAPT $26.56
- OCCI $10.15
- Technical
- Relative Strength Index (RSI)
- RAPT 63.64
- OCCI 49.31
- Support Level
- RAPT $11.19
- OCCI $5.85
- Resistance Level
- RAPT $13.66
- OCCI $6.00
- Average True Range (ATR)
- RAPT 0.75
- OCCI 0.11
- MACD
- RAPT 0.19
- OCCI 0.03
- Stochastic Oscillator
- RAPT 86.53
- OCCI 68.60
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.